Nasdaq · CIK 0001178253
SCYX SCYNEXIS INC
Insider trading from SEC Form 4. Last filing 20 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Signals
Open-market buys and sells at SCYNEXIS INC, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 21 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Steven Keith Burke director | AGrant or award Common Stock | +5,750 | $0.00 | $0 | 5,750 | 20 d ago |
| Sep 18, 2026 | Steven Keith Burke director | AGrant or award Stock Option (Right to Buy)derivative | +5,750 | $0.00 | $0 | 5,750 | 20 d ago |
| Sep 9, 2026 | Sanjay Subramanian Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | 31 d ago |
| Oct 17, 2025 | Gonzalez David Angulo Chief Executive Officer | AGrant or award Common Stock | +32,500 | $0.76 | $25k | 853,098 | Oct 21, 2025 |
| Jun 26, 2025 | David C Hastings director | AGrant or award Common Stock | +23,000 | $0.00 | $0 | 69,183 | Jun 30, 2025 |
| Jun 26, 2025 | Brian Philippe Tinmouth director | AGrant or award Common Stock | +23,000 | $0.00 | $0 | 74,000 | Jun 30, 2025 |
| Jun 26, 2025 | Guy Macdonald director | AGrant or award Common Stock | +23,000 | $0.00 | $0 | 78,000 | Jun 30, 2025 |
| Jun 26, 2025 | Ann Hanham director | AGrant or award Common Stock | +23,000 | $0.00 | $0 | 69,622 | Jun 30, 2025 |
| Jun 26, 2025 | Steven C Gilman director | AGrant or award Common stock | +23,000 | $0.00 | $0 | 70,000 | Jun 30, 2025 |
| Jun 26, 2025 | Armando Anido director | AGrant or award Common Stock | +23,000 | $0.00 | $0 | 71,000 | Jun 30, 2025 |
| Jun 26, 2025 | Steven C Gilman director | AGrant or award Stock Optionderivative | +23,000 | $0.00 | $0 | 23,000 | Jun 30, 2025 |
| Jun 26, 2025 | Ann Hanham director | AGrant or award Stock Optionderivative | +23,000 | $0.00 | $0 | 23,000 | Jun 30, 2025 |
| Jun 26, 2025 | David C Hastings director | AGrant or award Stock Optionderivative | +23,000 | $0.00 | $0 | 23,000 | Jun 30, 2025 |
| Jun 26, 2025 | Armando Anido director | AGrant or award Stock Optionderivative | +23,000 | $0.00 | $0 | 23,000 | Jun 30, 2025 |
| Jun 26, 2025 | Guy Macdonald director | AGrant or award Stock Optionderivative | +23,000 | $0.00 | $0 | 23,000 | Jun 30, 2025 |
| Jun 26, 2025 | Brian Philippe Tinmouth director | AGrant or award Stock Optionderivative | +23,000 | $0.00 | $0 | 23,000 | Jun 30, 2025 |
| Apr 9, 2025 | Gonzalez David Angulo Chief Executive Officer | AGrant or award Common Stock | +23,000 | $0.84 | $19k | 816,598 | Apr 10, 2025 |
| Mar 19, 2025 | Gonzalez David Angulo Chief Executive Officer | AGrant or award Common Stock | +5,000 | $1.07 | $5,350 | 779,798 | Mar 20, 2025 |
| Mar 20, 2025 | Gonzalez David Angulo Chief Executive Officer | AGrant or award Common Stock | +13,800 | $1.05 | $14k | 793,598 | Mar 20, 2025 |
| Jan 23, 2025 | Gonzalez David Angulo Chief Executive Officer | AGrant or award Common Stock | +262,927 | $0.00 | $0 | 770,798 | Jan 27, 2025 |
| Jan 23, 2025 | Gonzalez David Angulo Chief Executive Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +394,391 | $0.00 | $0 | 394,391 | Jan 27, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Armando Anidodirector
- Gonzalez David AnguloChief Executive Officer
- Steven Keith Burkeofficer, director
- Steven C Gilmandirector
- Ann Hanhamdirector
- David C Hastingscfo, officer, director
- Guy Macdonalddirector
- Sanjay SubramanianChief Financial Officer
- Brian Philippe Tinmouthdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.